SNHG5 promotes proliferation and induces apoptosis in melanoma by sponging miR-155

Lu Yan, Suihai Wang, Yue Li, Linda Tognetti, Rui Tan, Kang Zeng, Elisa Pianigiani, Xiangbin Mi, Hui Li, Michele Fimiani, Pietro RubegniRSC 2018 · DOI · OpenAlex

Abstract

Melanoma is the most aggressive and lethal form of skin cancer, characterized by high metastatic potential and increasing incidence worldwide. Recent advances in genomic research have highlighted the significant roles of long non-coding RNAs (lncRNAs) in various malignancies. In this study, we investigate the role of Small nucleolar RNA host gene 5 (SNHG5) in melanoma progression. Our results demonstrate that SNHG5 is significantly upregulated in melanoma tissues and cell lines, and its high expression correlates with advanced clinical stages and poor patient prognosis. Functional studies show that SNHG5 knockdown inhibits cell proliferation and promotes apoptosis in vitro and suppresses tumor growth in vivo. Mechanistically, SNHG5 acts as a molecular sponge for miR-155, thereby modulating its tumor-suppressive functions. These findings suggest that the SNHG5/miR-155 axis is a critical regulator of melanoma development and represents a potential therapeutic target.

Introduction

Melanoma arises from the malignant transformation of melanocytes and is responsible for the majority of skin cancer-related deaths. Despite the development of targeted therapies and immunotherapies, the prognosis for patients with advanced melanoma remains poor due to primary or acquired resistance. Consequently, identifying novel molecular drivers and therapeutic targets is of paramount importance.

Long non-coding RNAs (lncRNAs) are transcripts longer than 200 nucleotides that lack significant protein-coding potential. They function as master regulators of gene expression at transcriptional, post-transcriptional, and epigenetic levels. SNHG5, a member of the small nucleolar RNA host gene family, has been reported to act as an oncogene in several cancers, including gastric and colorectal cancer. However, its specific role and underlying molecular mechanisms in melanoma have not been fully elucidated. This study aims to characterize the expression and function of SNHG5 in melanoma and explore its interaction with microRNAs.

Methods

Clinical Samples and Cell Culture

A total of 22 pairs of melanoma tissues and adjacent normal skin tissues were collected from patients. Five melanoma cell lines (HBL, A375, SK-MEL-2, CHL-1, and VMM917) and a control line of Normal Human Epidermal Melanocytes (NHEM) were utilized for in vitro analysis.

Expression Analysis

Quantitative real-time PCR (RT-qPCR) was employed to detect the expression levels of SNHG5 and miR-155 in both tissues and cell lines.

Functional Assays

To assess the biological impact of SNHG5, loss-of-function experiments were performed using small interfering RNAs (siRNAs) to knock down SNHG5 expression in A375 and SK-MEL-2 cells. Cell proliferation was assessed using MTT and colony formation assays. Apoptosis rates were determined by flow cytometry using Annexin V-FITC and propidium iodide (PI) double staining.

Mechanistic Studies

The subcellular localization of SNHG5 was determined by fractionating the cytoplasm and nucleus. Potential microRNA targets were predicted using the miRcode database. The physical interaction between SNHG5 and miR-155 was validated using dual-luciferase reporter assays and RNA immunoprecipitation (RIP) assays targeting the Ago2 protein.

In Vivo Xenograft Model

To verify the in vitro findings, a mouse xenograft model was established. Melanoma cells with stable SNHG5 knockdown were injected into nude mice, and tumor volume and weight were monitored over time. Additionally, the effect of miR-155 mimics on tumor growth was evaluated in this model.

Results

SNHG5 is Upregulated in Melanoma and Correlates with Poor Prognosis

RT-qPCR analysis revealed that SNHG5 expression was significantly elevated in melanoma tissues compared to normal skin. High SNHG5 levels were positively correlated with advanced TNM stages (III and IV) and were associated with significantly shorter overall survival in patients. Similarly, SNHG5 was found to be 3- to 5-fold more abundant in melanoma cell lines than in normal melanocytes.

SNHG5 Knockdown Inhibits Proliferation and Induces Apoptosis

Silencing SNHG5 in A375 and SK-MEL-2 cells led to a significant reduction in cell viability and a decrease in colony-forming capacity by more than 50%. Furthermore, SNHG5 depletion triggered a substantial increase in programmed cell death, with apoptosis rates rising from a baseline of ~4% to approximately 18-22% in knockdown cells.

SNHG5 Functions as a Molecular Sponge for miR-155

Subcellular fractionation showed that SNHG5 is primarily located in the cytoplasm, suggesting it may function as a competing endogenous RNA (ceRNA). Bioinformatics analysis identified a conserved binding site for miR-155 within SNHG5. Luciferase reporter assays confirmed that miR-155 directly binds to SNHG5. Furthermore, RIP assays demonstrated that both SNHG5 and miR-155 were enriched in Ago2-containing complexes, confirming their physical association.

Restoration of miR-155 Rescues SNHG5-Mediated Effects

To confirm that SNHG5 exerts its oncogenic effects through miR-155, restoration experiments were performed. The inhibition of cell proliferation and induction of apoptosis caused by SNHG5 knockdown were partially reversed when miR-155 was simultaneously inhibited. This indicates that the SNHG5/miR-155 axis is a primary driver of the observed phenotypes.

In Vivo Validation

In the xenograft model, tumors in the SNHG5 knockdown group grew significantly slower and reached smaller volumes and weights compared to control tumors. Injecting a miR-155 mimic into these tumors further enhanced the anti-tumor effect, confirming the oncogenic role of SNHG5 and the tumor-suppressive role of miR-155 in vivo.

Discussion

This study identifies SNHG5 as a key oncogenic lncRNA in melanoma. By sponging miR-155, SNHG5 promotes cell survival and proliferation. The correlation between SNHG5 expression and clinical outcomes underscores its potential utility in patient stratification and prognosis.

While this study clearly defines the SNHG5/miR-155 interaction, it does not identify the downstream messenger RNAs (mRNAs) that miR-155 normally regulates. MicroRNAs usually work by silencing specific proteins; knowing which proteins are "released" when SNHG5 sponges miR-155 would provide a more complete picture of the signaling pathway. Additionally, the clinical sample size (n=22) is relatively small, and larger cohorts would be needed to validate SNHG5 as a robust clinical biomarker.

Conclusion

In summary, SNHG5 is upregulated in melanoma and promotes tumor progression by sponging miR-155. These findings highlight SNHG5 as a potential prognostic biomarker and a promising therapeutic target for the treatment of melanoma.

Summary updated

Abstract

<i>Background</i>: Melanoma is the most common malignancy of skin cancer. Small nucleolar RNA host gene 5 (SNHG5), a long non-coding RNA (lncRNA), has been demonstrated to be abnormally expressed in multiple malignances. However, the roles and molecular mechanisms of SNHG5 in melanoma progression have not been well identified. <i>Methods</i>: RT-qPCR assays were used to detect the expression patterns of SNHG5 and microRNA-155 (miR-155). Cell proliferation was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and colony formation assays. Cell apoptosis rate was measured by flow cytometry <i>via</i> double-staining of fluorescein isothiocyanate (FITC)-labeled annexin V (Annexin V-FITC) and propidium iodide (PI). The interaction between SNHG5 and miR-155 was validated using bioinformatics analysis, subcellular fraction assay, luciferase assay and RNA immunoprecipitation (RIP) assay. A mouse model of melanoma was established to further verify the effect of SNHG5 on tumor growth <i>in vivo</i>. <i>Results</i>: SNHG5 expression was upregulated in melanoma tumor tissues and cell lines. Moreover, higher SNHG5 expression was associated with advanced pathogenic status and poor prognosis. Functional analysis showed that SNHG5 knockdown suppressed proliferation and facilitated apoptosis in melanoma cells. Mechanical exploration revealed that SNHG5 acted as a molecular sponge of miR-155 in melanoma cells. Restoration experiments delineated that miR-155 down-regulation partly abrogated SNHG5-knockdown-mediated anti-proliferation and pro-apoptosis effect in melanoma cells. <i>In vivo</i> assays further demonstrated that SNHG5 depletion hindered tumor growth through up-regulating miR-155 expression. <i>Conclusion</i>: SNHG5 promoted the development of melanoma by sponging miR-155 <i>in vitro</i> and <i>in vivo</i>, implying the important implication of lncRNAs in melanoma progression and providing a potential therapeutic target for melanoma.
BibTeX
@inproceedings{yan2018snhg,
  author = {Lu Yan and Suihai Wang and Yue Li and Linda Tognetti and Rui Tan and Kang Zeng and Elisa Pianigiani and Xiangbin Mi and Hui Li and Michele Fimiani and Pietro Rubegni},
  title = {{SNHG5 promotes proliferation and induces apoptosis in melanoma by sponging miR-155}},
  booktitle = {RSC},
  year = {2018},
  doi = {10.1039/c7ra12520h},
}

Loading related content...

Figure